Objective-To determine the value of transoesophageal echocardiography in the assessment of selected patients at risk of cardiogenic embolism or after it.
Results-Transthoracic echocardiography showed potential sources of embolism in four patients including left ventricular thrombus in two patients (with one false positive), left atrial appendage thrombus (n = 1), and patent foramen ovale (n = 1). Transoesophageal echocardiography showed 59 potential embolic sources in 45 patients including left atrial spontaneous echo contrast (n = 33), left atrial appendage thrombus (n = 13), left ventricular thrombus (n = 5), patent foramen ovale (n = 3), left ventricular spontaneous echo contrast (n = 2), mitral valve prosthesis thrombus (n = 1), mitral valve prolapse (n = 1), and pronounced aortic atheroma (n = 1). Sixty three patients were referred for the detection of potential cardiac sources of emboli after a cerebral ischaemic event or acute peripheral arterial occlusion. Patients were selected for transoesophageal echocardiography if cardiogenic embolism was clinically suspected and if transthoracic echocardiography alone was considered unlikely to detect potential embolic sources. Studies were performed within one month of the event in 59/63 (94%) patients. Fifty two patients were studied after stroke or transient ischaemic attack. Cerebral infarction was shown by computed tomography or magnetic resonance imaging in 35/52 (67%) patients. The remaining 11 patients were studied after acute thromboembolism to the arm or leg, documented at surgery in 10/11 patients. Two patients referred after suspected embolism had mitral stenosis and six patients had a mitral valve prosthesis.
Twenty three patients were studied before elective percutaneous balloon dilatation of the mitral valve. Transoesophageal echocardiography was routinely performed one day before dilatation to assess mitral valve anatomy and function and to detect left atrial thrombi.
Fourteen patients were referred to exclude left atrial thrombus before elective DC cardioversion of atrial fibrillation. Atrial fibrillation had lasted less than one month in seven patients and more than one month in seven patients.
Transoesophageal echocardiography was unsuccessful in two additional patients, referred after stroke, who were excluded from further analysis. Oesophageal axis, four chamber, transgastric short axis, and views of the thoracic aorta were obtained. Particular attention was directed to the left atrial body and appendage and the interatrial septum. The left ventricular endocardium was examined in sequential transgastric short axis views as well as in four-chamber views.
Intracardiac thrombus was diagnosed by the presence of a clearly defined echodense intracavitary mass, acoustically distinct from the underlying endocardium and not caused by pectinate ridges of the atrial appendage. Mital valve prolapse was diagnosed by transoesophageal echocardiography according to previously reported criteria.9 From November 1989, contrast studies to detect a patient foramen ovale were performed during transoesophageal echocardiography in patients in whom no other source of embolism had been found (n = 25). Agitated saline containing air microbubbles was injected rapidly into an antecubital vein and the patient was instructed to perform a Valsalva manoeuvre or to cough.'6 A patent foramen ovale with right to left shunting was diagnosed if microbubbles were seem to cross the atrial septum into the left atrium and no septal defect was seen.
The study period lasted 10-20 minutes and technically adequate images were obtained in all studies. There were no complications. All clinical and echocardiographic data were recorded prospectively. Transoesophageal and transthoracic echocardiographic studies were performed and interpreted independently by different experienced echocardiographers, who were, however, not blinded to the transthoracic echocardiography results.
Differences in proportions were compared by the X 2 test with continuity correction. Statistical significance was defined as p < 0 05. Eleven of the 23 patients were in sinus rhythm and 12 were in atrial fibrillation. In the 11 patients in sinus rhythm (mean mitral valve area 1 0 cm') neither echocardiographic study showed thrombus while transoesophageal echocardiography alone showed left atrial spontaneous echo contrast in three patients.
Results
In 12 patients with atrial fibrillation (mean mitral valve area 1 2 cm2) transthoracic echocardiography showed a large left atrial appendage thrombus in only one patient, which was confirmed by transoesophageal echocardiography and subsequent surgery. In the remaining 11 patients, left atrial thrombus was shown by transoesophageal echocardiography in five, Non-valvar atrial fibrillation is the most common cardiac condition implicated in presumed embolic stroke, with a fivefold increase in stroke risk compared with sinus rhythm.20
Although surgical series show that a large proportion of left atrial thrombi are located in the appendage,2' 22 this structure is difficult to image with transthoracic echocardiography and thrombi in the left atrial appendage are rarely detected by this method.2' 22 In contrast, transoesophageal echocardiography provides high frequency, close range imaging of the left atrium and appendage, which allows visualisation of thrombus, spontaneous contrast, and other abnormalities.8 10 Our results confirm the improved yield of potential sources of embolism with transoesophageal echocardiography, particularly for left atrial thrombi (p < 0-005) and left atrial spontaneous echo contrast (p < 0-0001). Twelve of the 13 left atrial thrombi were found in patients with atrial fibrillation and in the 53 patients in atrial fibrillation transoesophageal echocardiography showed potential embolic sources in 36 but transthoracic echocardiography showed them in only one (p < 0-0001).
In our group of 63 patients referred after suspected cardiogenic embolism, we detected a potential embolic source by transoesophageal echocardiography in 27 patients (43%) compared with three (5%) (including one false positive) by transthoracic echocardiography (p < 0 0001). In 12 of these patients intracar-diac thrombus was detected only by transoesophageal echocardiography, and this resulted in warfarin treatment being started in two patients. The high yield of abnormal findings is related to our patient selection; we included patients with clinically suspected cardiogenic embolism and in whom transthoracic echocardiography alone was considered unlikely to detect potential embolic sources. In comparison, the incidence of thrombi detected by transoesophageal echocardiography in unselected patients with cerebral ischaemic events was 04%.1 23 Selection of patients for transoesophageal echocardiography should take into account both the likelihood of an abnormal finding and the potential impact on patient management.
Left atrial spontaneous echo contrast has recently attracted interest as a marker of thromboembolism.'4 Earlier work suggested that spontaneous echo contrast is caused by aggregates of red cells in low flow states;2425 platelets too may also be involved.26 Most patients with left atrial thrombi also have left atrial spontaneous contrast;'4 this was found in 10 of 13 patients in our series. Thus spontaneous echo contrast may prove to be a useful marker of sluggish blood flow-a condition favouring thrombus formation. In vitro data suggest that spontaneous echo contrast is not prevented by anticoagulant treatment.24 Indeed we found a higher incidence of both thrombi and spontaneous echo contrast in patients receiving warfarin, reflecting associated conditions such as atrial fibrillation, mitral valve replacement, and recent embolism.
We also studied patients before percutaneous balloon dilatation of the mitral valve and DC cardioversion of atrial fibrillation-both procedures with a risk of cardiogenic embolism. Half of the patients in our series with both atrial fibrillation and mitral stenosis were found to have previously unrecognised thrombi in the left atrial appendage; their discovery led to important changes in management. In addition, balloon dilatation of the mitral valve was performed without embolic complications in all patients without evidence of left atrial thrombus. We now perform transoesophageal echocardiography as a routine procedure before percutaneous balloon dilatation of the mitral valve. Cardioversion ofatrial fibrillation also carries a small risk of major systemic embolism, even with prior anticoagulation.5 A method of detecting left atrial thrombi or perhaps dense spontaneous echo contrast before cardioversion may allow the procedure to be timed more appropriately and the need for anticoagulation to be better assessed. In this series all patients in whom transoesophageal echocardiography did not show left atrial thrombus underwent cardioversion without embolic complications.
Our selection criteria limit extrapolation of our findings to all patients after stroke or transient ischaemic attack. Those who interpreted the transoesophageal echocardiographic results were not formally blinded to the transthoracic results. However, the studies were performed and reported independently and prospectively by separate experienced operators. Single plane transoesophageal echocardiography does not optimally visualise the left ventricular apex, which is in the far field of view, and small apical thrombi may be missed. Finally, there are few data on the correlation of echocardiographic and pathological findings for left atrial thrombi, although a preliminary report showed high sensitivity and specificity compared with surgical findings.27
Future indications for transoesophageal echocardiography may include the assessment of left atrial thrombi and spontaneous echo contrast in patients with non-valvar atrial fibrillation without previous embolism, in whom the risk ofstroke is fivefold higher than in patients in sinus rhythm.20 There Apart from being a dedicated and gifted clinician his main achievement was the creation of Withybush General Hospital in Haverfordwest, Pembrokeshire, which resulted out of his single-minded efforts. His contributions to postgraduate medicine in the area were recognised when the library in the postgraduate centre was named after him.
He will be remembered with affection by his many friends as an accomplished gardener, no mean wet fly fisher, and as a man who never gave up a cause-be it the developmment of his hospital or of academic cardiology in Cardiff. He is survived by his wife, three children, and seven grandchildren.
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